A case report of naltrexone treatment of self-injury and social withdrawal in autism
- PMID: 2189867
- DOI: 10.1007/BF02284716
A case report of naltrexone treatment of self-injury and social withdrawal in autism
Abstract
The endogenous opiate release theory of self-injurious behavior (SIB) was investigated through double-blind placebo-controlled administration of naltrexone hydrochloride (Trexan) to a 14-year-old autistic and mentally retarded male for treatment of severe SIB. Results yielded a marked decrease in SIB during two phases of active drug treatment, though SIB did not revert to originally observed placebo levels during a second placebo phase. An increase in social relatedness also was observed during phases of active drug treatment. Opiate theories of self-injury and the possible interrelationship of self-injury with pituitary-adrenal arousal and with social relatedness are discussed.
Similar articles
-
Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.Arch Gen Psychiatry. 1995 Sep;52(9):766-73. doi: 10.1001/archpsyc.1995.03950210060011. Arch Gen Psychiatry. 1995. PMID: 7654128 Clinical Trial.
-
Naltrexone attenuates self-injurious behavior in mentally retarded subjects.Biol Psychiatry. 1990 Apr 1;27(7):741-6. doi: 10.1016/0006-3223(90)90589-t. Biol Psychiatry. 1990. PMID: 2158355 Clinical Trial.
-
Effects of naloxone and naltrexone on self-injury: a double-blind, placebo-controlled analysis.Am J Ment Retard. 1989 May;93(6):644-51. Am J Ment Retard. 1989. PMID: 2655671 Clinical Trial.
-
[Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone].Encephale. 1993 Mar-Apr;19(2):95-102. Encephale. 1993. PMID: 8275903 Review. French.
-
Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.Ann Pharmacother. 2006 Jun;40(6):1086-95. doi: 10.1345/aph.1G499. Epub 2006 May 30. Ann Pharmacother. 2006. PMID: 16735648 Review.
Cited by
-
Brief report: a synopsis of an open-trial of naltrexone treatment of autism with four children.J Autism Dev Disord. 1991 Jun;21(2):243-9. doi: 10.1007/BF02284764. J Autism Dev Disord. 1991. PMID: 1864831 No abstract available.
-
Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach.J Autism Dev Disord. 2015 Jun;45(6):1541-68. doi: 10.1007/s10803-014-2307-3. J Autism Dev Disord. 2015. PMID: 25395094 Review.
-
Brief report: a double-blind study of naltrexone in infantile autism.J Autism Dev Disord. 1992 Jun;22(2):309-19. doi: 10.1007/BF01058158. J Autism Dev Disord. 1992. PMID: 1345670 Clinical Trial. No abstract available.
-
Microglia in the cerebral cortex in autism.J Autism Dev Disord. 2012 Dec;42(12):2569-84. doi: 10.1007/s10803-012-1513-0. J Autism Dev Disord. 2012. PMID: 22466688
-
Advances in the pharmacological treatment of pathological gambling.J Gambl Stud. 2003 Spring;19(1):85-109. doi: 10.1023/a:1021227214142. J Gambl Stud. 2003. PMID: 12635541 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical